'ProtecTion' from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?

نویسندگان

  • Luke L Wang
  • Christopher J D Wallis
  • Niranjan Sathianathen
  • Nathan Lawrentschuk
  • Declan G Murphy
  • Robert Nam
  • Daniel Moon
چکیده

randomized trial finally answer the key question in localized prostate cancer? Luke L. Wang*, Christopher J.D. Wallis, Niranjan Sathianathen, Nathan Lawrentschuk , Declan G. Murphy**, Robert Nam and Daniel Moon* *Australian Urology Associates, Malvern, Department of Surgery, Central Clinical School, Monash University, Melbourne, Vic., Australia, Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada, Division of Cancer Surgery, Peter MacCallum Cancer Centre, Department of Surgery, Austin Health, University of Melbourne, Melbourne, and **Australian Prostate Cancer Research Centre, Epworth Healthcare, Richmond, Vic., Australia

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

PSA Screening in Prostate Cancer

Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...

متن کامل

Prostate-specific antigen kinetics after hypofractionated stereotactic body radiotherapy for localized prostate cancer

Background: stereotactic body radiotherapy (SBRT) has emerged as an effective treatment for localized prostate cancer. However, prostate-specific antigen (PSA) kinetics after SBRT has not been well characterized. The objective of the current study is to analyze the rate of PSA decline and PSA nadir following hypofractonated SBRT in localized prostate cancer. Materials and Methods: From 2008...

متن کامل

Prostate-Specific Antigen-Based Prostate Cancer Screening

Serum prostate-specific antigen (PSA) testing is a simple and effective method for diagnosing prostate cancer. The widespread PSA screening resulted in increased diagnosis of early-staged, localized prostate cancer and marked reduction in advanced, metastatic cancer, which contributed to subsequent reduction in prostate cancer mortality. Most patients with localized prostate cancer, especially ...

متن کامل

Assessing the Diagnostic Value of Plasma-Free DNA in Prostate Cancer Screening

Background: Prostate cancer is the second form of cancer among men worldwide. For early cancer detection, we should identify tumors in initial stages before the physical signs become visible. The present study aims to evaluate the diagnostic value of cell-free DNA (cfDNA), its comparison with prostate-specific antigen (PSA) level in prostate cancer screening and also in patients with localized ...

متن کامل

Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan

Despite treatment guidelines recommending observation for men with low-risk prostate cancer with life expectancy <10 years, a majority of elderly patients choose active treatment, which may result in overtreatment. Given the growing burden of prostate cancer among men aged ≥80 years (super-elderly men), accumulation of survival data for evaluation of overtreatment among super-elderly patients i...

متن کامل

ذخیره در منابع من

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • BJU international

دوره 119 4  شماره 

صفحات  -

تاریخ انتشار 2017